Novel tumor microenvironment (TME) restored 3D cell culture model and humanized patient-derived xenograft model for cancer research and drug evaluation

被引:0
|
作者
Zhang, Jing
Yang, Dabing
Wang, Huilin
Song, Qiong
Li, Hui
Shaw, J. P.
Deng, Tianjing
机构
关键词
D O I
10.1158/1538-7445.AM2016-4261
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
4261
引用
收藏
页数:2
相关论文
共 50 条
  • [41] Evaluation of anti-tumorigenic activity of BP3B against colon cancer with patient-derived tumor xenograft model
    Hye-Youn Kim
    Jinhee Kim
    Huyen Trang Ha Thi
    Ok-Sun Bang
    Won-Suk Lee
    Suntaek Hong
    [J]. BMC Complementary and Alternative Medicine, 16
  • [42] Application of triple negative breast cancer patient-derived organoid and xenograft model for drug screening
    Ryu, Seungyeon
    Kim, Hoe Suk
    Kim, Jung Eun
    Yoon, So-Hyun
    Lee, Sangeun
    Baek, Moonjou
    Lee, Han-Byoel
    Lee, Dong Woo
    Ku, Bosung
    Han, Wonshik
    [J]. CANCER RESEARCH, 2022, 82 (12)
  • [43] Breast cancer patient-derived whole-tumor cell culture model for efficient drug profiling and treatment response prediction
    Chen, Xinsong
    Sifakis, Emmanouil G.
    Robertson, Stephanie
    Neo, Shi Yong
    Jun, Seong-Hwan
    Tong, Le
    Min, Apple Tay Hui
    Lovrot, John
    Hellgren, Roxanna
    Margolin, Sara
    Bergh, Jonas
    Foukakis, Theodoros
    Lagergren, Jens
    Lundqvist, Andreas
    Ma, Ran
    Hartman, Johan
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2023, 120 (01)
  • [44] Drug resistance profiling of a new triple negative breast cancer patient-derived xenograft model
    Matossian, Margarite D.
    Burks, Hope E.
    Elliott, Steven
    Hoang, Van T.
    Bowles, Annie C.
    Sabol, Rachel A.
    Wahba, Bahia
    Anbalagan, Muralidharan
    Rowan, Brian
    Abazeed, Mohamed E.
    Bunnell, Bruce A.
    Moroz, Krzysztof
    Miele, Lucio
    Rhodes, Lyndsay V.
    Jones, Steven D.
    Martin, Elizabeth C.
    Collins-Burow, Bridgette M.
    Burow, Matthew E.
    [J]. BMC CANCER, 2019, 19 (1)
  • [45] Identifying resistance mechanisms in breast cancer in patient-derived organoids and 3D cell culture
    Classen, S.
    Rahlf, E.
    Petersen, C.
    Rothkamm, K.
    Toulany, M.
    Cordes, N.
    Borgmann, K.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S1645 - S1646
  • [46] Enhanced activity of aflibercept compared to bevacizumab in a patient-derived xenograft colorectal cancer model is associated with reduced tumor vascularity in humanized VEGF mice
    Abrahams, Cristina L.
    Winters, Laura D.
    Li, Baosheng
    Parveen, Asma A.
    Kloss, Tatjana
    Bagley, Rebecca G.
    Bergstrom, Donald A.
    Thurston, Gavin
    Chiron, Marielle
    [J]. CANCER RESEARCH, 2014, 74 (19)
  • [47] Establishment of Patient-Derived Tumor Xenograft Models of Epithelial Ovarian Cancer for Preclinical Evaluation of Novel Therapeutics
    Liu, Joyce F.
    Palakurthi, Sangeetha
    Zeng, Qing
    Zhou, Shan
    Ivanova, Elena
    Huang, Wei
    Zervantonakis, Ioannis K.
    Selfors, Laura M.
    Shen, Yiping
    Pritchard, Colin C.
    Zheng, Mei
    Adleff, Vilmos
    Papp, Eniko
    Piao, Huiying
    Novak, Marian
    Fotheringham, Susan
    Wulf, Gerburg M.
    English, Jessie
    Kirschmeier, Paul T.
    Velculescu, Victor E.
    Paweletz, Cloud
    Mills, Gordon B.
    Livingston, David M.
    Brugge, Joan S.
    Matulonis, Ursula A.
    Drapkin, Ronny
    [J]. CLINICAL CANCER RESEARCH, 2017, 23 (05) : 1263 - 1273
  • [48] Novel patient-derived orthotopic xenograft model for preclinical studies of breast cancer brain metastasis
    Oshi, Masanori
    Okano, Maiko
    Takabe, Kazuaki
    [J]. CANCER RESEARCH, 2020, 80 (16)
  • [49] Development and Characterization of a Novel Human Xenograft Model Using an MDS Patient-Derived Cell Line
    Rhyasen, Garrett
    Wunderlich, Mark
    Mulloy, James C.
    Starczynowski, Daniel T.
    [J]. BLOOD, 2012, 120 (21)
  • [50] The combinational therapy of trastuzumab and cetuximab inhibits tumor growth in a patient-derived tumor xenograft model of gastric cancer
    C. J. Wang
    P. J. Tong
    M. Y. Zhu
    [J]. Clinical and Translational Oncology, 2016, 18 : 507 - 514